Global Gastrointestinal Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Gastrointestinal Therapeutics market size was valued at US$ 33390 million in 2023. With growing demand in downstream market, the Gastrointestinal Therapeutics is forecast to a readjusted size of US$ 48570 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Gastrointestinal Therapeutics market. Gastrointestinal Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gastrointestinal Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gastrointestinal Therapeutics market.
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Key Features:
The report on Gastrointestinal Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gastrointestinal Therapeutics market. It may include historical data, market segmentation by Type (e.g., Oral, Parenteral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gastrointestinal Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gastrointestinal Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gastrointestinal Therapeutics industry. This include advancements in Gastrointestinal Therapeutics technology, Gastrointestinal Therapeutics new entrants, Gastrointestinal Therapeutics new investment, and other innovations that are shaping the future of Gastrointestinal Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gastrointestinal Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Gastrointestinal Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gastrointestinal Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gastrointestinal Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gastrointestinal Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gastrointestinal Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gastrointestinal Therapeutics market.
Market Segmentation:
Gastrointestinal Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Gastrointestinal Therapeutics market size was valued at US$ 33390 million in 2023. With growing demand in downstream market, the Gastrointestinal Therapeutics is forecast to a readjusted size of US$ 48570 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Gastrointestinal Therapeutics market. Gastrointestinal Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gastrointestinal Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gastrointestinal Therapeutics market.
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Key Features:
The report on Gastrointestinal Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gastrointestinal Therapeutics market. It may include historical data, market segmentation by Type (e.g., Oral, Parenteral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gastrointestinal Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gastrointestinal Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gastrointestinal Therapeutics industry. This include advancements in Gastrointestinal Therapeutics technology, Gastrointestinal Therapeutics new entrants, Gastrointestinal Therapeutics new investment, and other innovations that are shaping the future of Gastrointestinal Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gastrointestinal Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Gastrointestinal Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gastrointestinal Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gastrointestinal Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gastrointestinal Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gastrointestinal Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gastrointestinal Therapeutics market.
Market Segmentation:
Gastrointestinal Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Oral
- Parenteral
- IBD
- Irritable Bowel Syndrome (IBS)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Allergan
- Johnson & Johnson
- Takeda
- Novartis
- Pfizer
- Merck
- F. Hoffmann-La Roche
- Eli Lilly
- AstraZeneca
- Procter & Gamble
- Tillotts Pharma
- Takeda
- GlaxoSmithKline
- Amgen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Therapeutics Market Size 2019-2030
2.1.2 Gastrointestinal Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gastrointestinal Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 Gastrointestinal Therapeutics Market Size by Type
2.3.1 Gastrointestinal Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Gastrointestinal Therapeutics Segment by Application
2.4.1 IBD
2.4.2 Irritable Bowel Syndrome (IBS)
2.5 Gastrointestinal Therapeutics Market Size by Application
2.5.1 Gastrointestinal Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
3 GASTROINTESTINAL THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Gastrointestinal Therapeutics Market Size Market Share by Players
3.1.1 Global Gastrointestinal Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL THERAPEUTICS BY REGIONS
4.1 Gastrointestinal Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Gastrointestinal Therapeutics Market Size Growth (2019-2024)
4.3 APAC Gastrointestinal Therapeutics Market Size Growth (2019-2024)
4.4 Europe Gastrointestinal Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Gastrointestinal Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gastrointestinal Therapeutics Market Size by Country (2019-2024)
5.2 Americas Gastrointestinal Therapeutics Market Size by Type (2019-2024)
5.3 Americas Gastrointestinal Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Therapeutics Market Size by Region (2019-2024)
6.2 APAC Gastrointestinal Therapeutics Market Size by Type (2019-2024)
6.3 APAC Gastrointestinal Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Therapeutics by Country (2019-2024)
7.2 Europe Gastrointestinal Therapeutics Market Size by Type (2019-2024)
7.3 Europe Gastrointestinal Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET FORECAST
10.1 Global Gastrointestinal Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Gastrointestinal Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Gastrointestinal Therapeutics Forecast
10.1.3 APAC Gastrointestinal Therapeutics Forecast
10.1.4 Europe Gastrointestinal Therapeutics Forecast
10.1.5 Middle East & Africa Gastrointestinal Therapeutics Forecast
10.2 Americas Gastrointestinal Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Gastrointestinal Therapeutics Market Forecast
10.2.2 Canada Gastrointestinal Therapeutics Market Forecast
10.2.3 Mexico Gastrointestinal Therapeutics Market Forecast
10.2.4 Brazil Gastrointestinal Therapeutics Market Forecast
10.3 APAC Gastrointestinal Therapeutics Forecast by Region (2025-2030)
10.3.1 China Gastrointestinal Therapeutics Market Forecast
10.3.2 Japan Gastrointestinal Therapeutics Market Forecast
10.3.3 Korea Gastrointestinal Therapeutics Market Forecast
10.3.4 Southeast Asia Gastrointestinal Therapeutics Market Forecast
10.3.5 India Gastrointestinal Therapeutics Market Forecast
10.3.6 Australia Gastrointestinal Therapeutics Market Forecast
10.4 Europe Gastrointestinal Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Gastrointestinal Therapeutics Market Forecast
10.4.2 France Gastrointestinal Therapeutics Market Forecast
10.4.3 UK Gastrointestinal Therapeutics Market Forecast
10.4.4 Italy Gastrointestinal Therapeutics Market Forecast
10.4.5 Russia Gastrointestinal Therapeutics Market Forecast
10.5 Middle East & Africa Gastrointestinal Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Gastrointestinal Therapeutics Market Forecast
10.5.2 South Africa Gastrointestinal Therapeutics Market Forecast
10.5.3 Israel Gastrointestinal Therapeutics Market Forecast
10.5.4 Turkey Gastrointestinal Therapeutics Market Forecast
10.5.5 GCC Countries Gastrointestinal Therapeutics Market Forecast
10.6 Global Gastrointestinal Therapeutics Forecast by Type (2025-2030)
10.7 Global Gastrointestinal Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Gastrointestinal Therapeutics Product Offered
11.1.3 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Gastrointestinal Therapeutics Product Offered
11.2.3 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Gastrointestinal Therapeutics Product Offered
11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Gastrointestinal Therapeutics Product Offered
11.4.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Gastrointestinal Therapeutics Product Offered
11.5.3 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Gastrointestinal Therapeutics Product Offered
11.6.3 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Gastrointestinal Therapeutics Product Offered
11.7.3 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Information
11.8.2 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Offered
11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 F. Hoffmann-La Roche Main Business Overview
11.8.5 F. Hoffmann-La Roche Latest Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Gastrointestinal Therapeutics Product Offered
11.9.3 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eli Lilly Main Business Overview
11.9.5 Eli Lilly Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Gastrointestinal Therapeutics Product Offered
11.10.3 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Procter & Gamble
11.11.1 Procter & Gamble Company Information
11.11.2 Procter & Gamble Gastrointestinal Therapeutics Product Offered
11.11.3 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Procter & Gamble Main Business Overview
11.11.5 Procter & Gamble Latest Developments
11.12 Tillotts Pharma
11.12.1 Tillotts Pharma Company Information
11.12.2 Tillotts Pharma Gastrointestinal Therapeutics Product Offered
11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Tillotts Pharma Main Business Overview
11.12.5 Tillotts Pharma Latest Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Gastrointestinal Therapeutics Product Offered
11.13.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Takeda Main Business Overview
11.13.5 Takeda Latest Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Information
11.14.2 GlaxoSmithKline Gastrointestinal Therapeutics Product Offered
11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 GlaxoSmithKline Main Business Overview
11.14.5 GlaxoSmithKline Latest Developments
11.15 Amgen
11.15.1 Amgen Company Information
11.15.2 Amgen Gastrointestinal Therapeutics Product Offered
11.15.3 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Amgen Main Business Overview
11.15.5 Amgen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Therapeutics Market Size 2019-2030
2.1.2 Gastrointestinal Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gastrointestinal Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 Gastrointestinal Therapeutics Market Size by Type
2.3.1 Gastrointestinal Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Gastrointestinal Therapeutics Segment by Application
2.4.1 IBD
2.4.2 Irritable Bowel Syndrome (IBS)
2.5 Gastrointestinal Therapeutics Market Size by Application
2.5.1 Gastrointestinal Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
3 GASTROINTESTINAL THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Gastrointestinal Therapeutics Market Size Market Share by Players
3.1.1 Global Gastrointestinal Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL THERAPEUTICS BY REGIONS
4.1 Gastrointestinal Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Gastrointestinal Therapeutics Market Size Growth (2019-2024)
4.3 APAC Gastrointestinal Therapeutics Market Size Growth (2019-2024)
4.4 Europe Gastrointestinal Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Gastrointestinal Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gastrointestinal Therapeutics Market Size by Country (2019-2024)
5.2 Americas Gastrointestinal Therapeutics Market Size by Type (2019-2024)
5.3 Americas Gastrointestinal Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Therapeutics Market Size by Region (2019-2024)
6.2 APAC Gastrointestinal Therapeutics Market Size by Type (2019-2024)
6.3 APAC Gastrointestinal Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Therapeutics by Country (2019-2024)
7.2 Europe Gastrointestinal Therapeutics Market Size by Type (2019-2024)
7.3 Europe Gastrointestinal Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET FORECAST
10.1 Global Gastrointestinal Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Gastrointestinal Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Gastrointestinal Therapeutics Forecast
10.1.3 APAC Gastrointestinal Therapeutics Forecast
10.1.4 Europe Gastrointestinal Therapeutics Forecast
10.1.5 Middle East & Africa Gastrointestinal Therapeutics Forecast
10.2 Americas Gastrointestinal Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Gastrointestinal Therapeutics Market Forecast
10.2.2 Canada Gastrointestinal Therapeutics Market Forecast
10.2.3 Mexico Gastrointestinal Therapeutics Market Forecast
10.2.4 Brazil Gastrointestinal Therapeutics Market Forecast
10.3 APAC Gastrointestinal Therapeutics Forecast by Region (2025-2030)
10.3.1 China Gastrointestinal Therapeutics Market Forecast
10.3.2 Japan Gastrointestinal Therapeutics Market Forecast
10.3.3 Korea Gastrointestinal Therapeutics Market Forecast
10.3.4 Southeast Asia Gastrointestinal Therapeutics Market Forecast
10.3.5 India Gastrointestinal Therapeutics Market Forecast
10.3.6 Australia Gastrointestinal Therapeutics Market Forecast
10.4 Europe Gastrointestinal Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Gastrointestinal Therapeutics Market Forecast
10.4.2 France Gastrointestinal Therapeutics Market Forecast
10.4.3 UK Gastrointestinal Therapeutics Market Forecast
10.4.4 Italy Gastrointestinal Therapeutics Market Forecast
10.4.5 Russia Gastrointestinal Therapeutics Market Forecast
10.5 Middle East & Africa Gastrointestinal Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Gastrointestinal Therapeutics Market Forecast
10.5.2 South Africa Gastrointestinal Therapeutics Market Forecast
10.5.3 Israel Gastrointestinal Therapeutics Market Forecast
10.5.4 Turkey Gastrointestinal Therapeutics Market Forecast
10.5.5 GCC Countries Gastrointestinal Therapeutics Market Forecast
10.6 Global Gastrointestinal Therapeutics Forecast by Type (2025-2030)
10.7 Global Gastrointestinal Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Gastrointestinal Therapeutics Product Offered
11.1.3 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Gastrointestinal Therapeutics Product Offered
11.2.3 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Gastrointestinal Therapeutics Product Offered
11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Gastrointestinal Therapeutics Product Offered
11.4.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Gastrointestinal Therapeutics Product Offered
11.5.3 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Gastrointestinal Therapeutics Product Offered
11.6.3 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Gastrointestinal Therapeutics Product Offered
11.7.3 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Information
11.8.2 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Offered
11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 F. Hoffmann-La Roche Main Business Overview
11.8.5 F. Hoffmann-La Roche Latest Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Gastrointestinal Therapeutics Product Offered
11.9.3 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eli Lilly Main Business Overview
11.9.5 Eli Lilly Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Gastrointestinal Therapeutics Product Offered
11.10.3 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Procter & Gamble
11.11.1 Procter & Gamble Company Information
11.11.2 Procter & Gamble Gastrointestinal Therapeutics Product Offered
11.11.3 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Procter & Gamble Main Business Overview
11.11.5 Procter & Gamble Latest Developments
11.12 Tillotts Pharma
11.12.1 Tillotts Pharma Company Information
11.12.2 Tillotts Pharma Gastrointestinal Therapeutics Product Offered
11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Tillotts Pharma Main Business Overview
11.12.5 Tillotts Pharma Latest Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Gastrointestinal Therapeutics Product Offered
11.13.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Takeda Main Business Overview
11.13.5 Takeda Latest Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Information
11.14.2 GlaxoSmithKline Gastrointestinal Therapeutics Product Offered
11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 GlaxoSmithKline Main Business Overview
11.14.5 GlaxoSmithKline Latest Developments
11.15 Amgen
11.15.1 Amgen Company Information
11.15.2 Amgen Gastrointestinal Therapeutics Product Offered
11.15.3 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Amgen Main Business Overview
11.15.5 Amgen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 2. Major Players of Oral
Table 3. Major Players of Parenteral
Table 4. Gastrointestinal Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Gastrointestinal Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Gastrointestinal Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Gastrointestinal Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Gastrointestinal Therapeutics Key Players Head office and Products Offered
Table 13. Gastrointestinal Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gastrointestinal Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Gastrointestinal Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Gastrointestinal Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Gastrointestinal Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Gastrointestinal Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Gastrointestinal Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Gastrointestinal Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Gastrointestinal Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Gastrointestinal Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Gastrointestinal Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Gastrointestinal Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Gastrointestinal Therapeutics
Table 45. Key Market Challenges & Risks of Gastrointestinal Therapeutics
Table 46. Key Industry Trends of Gastrointestinal Therapeutics
Table 47. Global Gastrointestinal Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Gastrointestinal Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Gastrointestinal Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Gastrointestinal Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. AbbVie Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 52. AbbVie Gastrointestinal Therapeutics Product Offered
Table 53. AbbVie Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. AbbVie Main Business
Table 55. AbbVie Latest Developments
Table 56. Allergan Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 57. Allergan Gastrointestinal Therapeutics Product Offered
Table 58. Allergan Main Business
Table 59. Allergan Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Allergan Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 62. Johnson & Johnson Gastrointestinal Therapeutics Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. Takeda Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 67. Takeda Gastrointestinal Therapeutics Product Offered
Table 68. Takeda Main Business
Table 69. Takeda Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Takeda Latest Developments
Table 71. Novartis Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 72. Novartis Gastrointestinal Therapeutics Product Offered
Table 73. Novartis Main Business
Table 74. Novartis Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Novartis Latest Developments
Table 76. Pfizer Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 77. Pfizer Gastrointestinal Therapeutics Product Offered
Table 78. Pfizer Main Business
Table 79. Pfizer Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Pfizer Latest Developments
Table 81. Merck Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 82. Merck Gastrointestinal Therapeutics Product Offered
Table 83. Merck Main Business
Table 84. Merck Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Merck Latest Developments
Table 86. F. Hoffmann-La Roche Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 87. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Offered
Table 88. F. Hoffmann-La Roche Main Business
Table 89. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. F. Hoffmann-La Roche Latest Developments
Table 91. Eli Lilly Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 92. Eli Lilly Gastrointestinal Therapeutics Product Offered
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Eli Lilly Latest Developments
Table 96. AstraZeneca Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 97. AstraZeneca Gastrointestinal Therapeutics Product Offered
Table 98. AstraZeneca Main Business
Table 99. AstraZeneca Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. AstraZeneca Latest Developments
Table 101. Procter & Gamble Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 102. Procter & Gamble Gastrointestinal Therapeutics Product Offered
Table 103. Procter & Gamble Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Procter & Gamble Main Business
Table 105. Procter & Gamble Latest Developments
Table 106. Tillotts Pharma Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 107. Tillotts Pharma Gastrointestinal Therapeutics Product Offered
Table 108. Tillotts Pharma Main Business
Table 109. Tillotts Pharma Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Tillotts Pharma Latest Developments
Table 111. Takeda Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 112. Takeda Gastrointestinal Therapeutics Product Offered
Table 113. Takeda Main Business
Table 114. Takeda Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Takeda Latest Developments
Table 116. GlaxoSmithKline Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 117. GlaxoSmithKline Gastrointestinal Therapeutics Product Offered
Table 118. GlaxoSmithKline Main Business
Table 119. GlaxoSmithKline Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. GlaxoSmithKline Latest Developments
Table 121. Amgen Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 122. Amgen Gastrointestinal Therapeutics Product Offered
Table 123. Amgen Main Business
Table 124. Amgen Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Amgen Latest Developments
Table 2. Major Players of Oral
Table 3. Major Players of Parenteral
Table 4. Gastrointestinal Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Gastrointestinal Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Gastrointestinal Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Gastrointestinal Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Gastrointestinal Therapeutics Key Players Head office and Products Offered
Table 13. Gastrointestinal Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gastrointestinal Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Gastrointestinal Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Gastrointestinal Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Gastrointestinal Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Gastrointestinal Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Gastrointestinal Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Gastrointestinal Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Gastrointestinal Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Gastrointestinal Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Gastrointestinal Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Gastrointestinal Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Gastrointestinal Therapeutics
Table 45. Key Market Challenges & Risks of Gastrointestinal Therapeutics
Table 46. Key Industry Trends of Gastrointestinal Therapeutics
Table 47. Global Gastrointestinal Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Gastrointestinal Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Gastrointestinal Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Gastrointestinal Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. AbbVie Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 52. AbbVie Gastrointestinal Therapeutics Product Offered
Table 53. AbbVie Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. AbbVie Main Business
Table 55. AbbVie Latest Developments
Table 56. Allergan Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 57. Allergan Gastrointestinal Therapeutics Product Offered
Table 58. Allergan Main Business
Table 59. Allergan Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Allergan Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 62. Johnson & Johnson Gastrointestinal Therapeutics Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. Takeda Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 67. Takeda Gastrointestinal Therapeutics Product Offered
Table 68. Takeda Main Business
Table 69. Takeda Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Takeda Latest Developments
Table 71. Novartis Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 72. Novartis Gastrointestinal Therapeutics Product Offered
Table 73. Novartis Main Business
Table 74. Novartis Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Novartis Latest Developments
Table 76. Pfizer Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 77. Pfizer Gastrointestinal Therapeutics Product Offered
Table 78. Pfizer Main Business
Table 79. Pfizer Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Pfizer Latest Developments
Table 81. Merck Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 82. Merck Gastrointestinal Therapeutics Product Offered
Table 83. Merck Main Business
Table 84. Merck Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Merck Latest Developments
Table 86. F. Hoffmann-La Roche Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 87. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Offered
Table 88. F. Hoffmann-La Roche Main Business
Table 89. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. F. Hoffmann-La Roche Latest Developments
Table 91. Eli Lilly Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 92. Eli Lilly Gastrointestinal Therapeutics Product Offered
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Eli Lilly Latest Developments
Table 96. AstraZeneca Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 97. AstraZeneca Gastrointestinal Therapeutics Product Offered
Table 98. AstraZeneca Main Business
Table 99. AstraZeneca Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. AstraZeneca Latest Developments
Table 101. Procter & Gamble Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 102. Procter & Gamble Gastrointestinal Therapeutics Product Offered
Table 103. Procter & Gamble Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Procter & Gamble Main Business
Table 105. Procter & Gamble Latest Developments
Table 106. Tillotts Pharma Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 107. Tillotts Pharma Gastrointestinal Therapeutics Product Offered
Table 108. Tillotts Pharma Main Business
Table 109. Tillotts Pharma Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Tillotts Pharma Latest Developments
Table 111. Takeda Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 112. Takeda Gastrointestinal Therapeutics Product Offered
Table 113. Takeda Main Business
Table 114. Takeda Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Takeda Latest Developments
Table 116. GlaxoSmithKline Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 117. GlaxoSmithKline Gastrointestinal Therapeutics Product Offered
Table 118. GlaxoSmithKline Main Business
Table 119. GlaxoSmithKline Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. GlaxoSmithKline Latest Developments
Table 121. Amgen Details, Company Type, Gastrointestinal Therapeutics Area Served and Its Competitors
Table 122. Amgen Gastrointestinal Therapeutics Product Offered
Table 123. Amgen Main Business
Table 124. Amgen Gastrointestinal Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Amgen Latest Developments
LIST OF FIGURES
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gastrointestinal Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastrointestinal Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Gastrointestinal Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastrointestinal Therapeutics Market Size Market Share by Type in 2023
Figure 10. Gastrointestinal Therapeutics in IBD
Figure 11. Global Gastrointestinal Therapeutics Market: IBD (2019-2024) & ($ Millions)
Figure 12. Gastrointestinal Therapeutics in Irritable Bowel Syndrome (IBS)
Figure 13. Global Gastrointestinal Therapeutics Market: Irritable Bowel Syndrome (IBS) (2019-2024) & ($ Millions)
Figure 14. Global Gastrointestinal Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Gastrointestinal Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Gastrointestinal Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Gastrointestinal Therapeutics Value Market Share by Country in 2023
Figure 22. United States Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Gastrointestinal Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Gastrointestinal Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Gastrointestinal Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Gastrointestinal Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Gastrointestinal Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Gastrointestinal Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gastrointestinal Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastrointestinal Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Gastrointestinal Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastrointestinal Therapeutics Market Size Market Share by Type in 2023
Figure 10. Gastrointestinal Therapeutics in IBD
Figure 11. Global Gastrointestinal Therapeutics Market: IBD (2019-2024) & ($ Millions)
Figure 12. Gastrointestinal Therapeutics in Irritable Bowel Syndrome (IBS)
Figure 13. Global Gastrointestinal Therapeutics Market: Irritable Bowel Syndrome (IBS) (2019-2024) & ($ Millions)
Figure 14. Global Gastrointestinal Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Gastrointestinal Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Gastrointestinal Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Gastrointestinal Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Gastrointestinal Therapeutics Value Market Share by Country in 2023
Figure 22. United States Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Gastrointestinal Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Gastrointestinal Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Gastrointestinal Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Gastrointestinal Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Gastrointestinal Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Gastrointestinal Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Gastrointestinal Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Gastrointestinal Therapeutics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Pharmaceutical Autoclaves Market Growth 2025-2031
US$ 3,660.00
March 2025
118 pages
Global Cardiovascular Ultrasound System Market Growth 2025-2031
US$ 3,660.00
January 2025
122 pages
Global mRNA Vaccines for Infectious Diseases Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
102 pages
Global Amalgam Plugger Market Growth 2023-2029
US$ 3,660.00
March 2023
93 pages
Global Rhinitis Semiconductor Treatment Instrument Market Growth 2023-2029
US$ 3,660.00
February 2023
98 pages
